Wednesday 2 December 2015

xarelto class action

Xarelto is part of the new production of anti-coagulants that have been linked to fatal bleeding with no reversal agent forcing Xarelto Lawyers to file Xarelto lawsuits on behalf of the patients who took the medication. Reversal agents are crucial in emergency situations. Unlike rival medications such as Pradaxa, emergency dialysis is not able to safely remove the drug from the patient’s system leading to death. Bayer knew about the serious health risks with Xarelto and failed to indicate them in any warnings. Despite the apparent danger of the medication, Bayer and its partner, Johnson & Johnson, continued to engage in a major marketing campaign to push the sales of Xarelto.

For more information visit on this check out here.

No comments:

Post a Comment